Skip to content
Screener

Tyra Biosciences, Inc. TYRA Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$39.31M-39.6%-$33.83M-32.3%-$29.87M-24.4%-$28.1M-50.2%-$28.15M-54.7%
$138K-3.5%$132K-8.3%$131K+3.1%$140K+11.1%$143K+17.2%
$7.85M+22.2%$7.63M+13.8%$7.58M+0.1%$6.38M+44.6%$6.42M+56.1%
-$32.57M-27.9%-$23.62M-20.6%-$22.38M-25.0%-$23.68M-131%-$25.46M-15.6%
$88K+529%$57K+850%$39K-25.0%$31K-93.4%$14K-89.7%
-$120.24M-475%$34.38M$20.87M+114%$32.03M+77.2%
$160.38M+7,233%$4.68M+563%$647K-12.9%$583K+56.3%$2.19M-98.9%
$7.57M-13.6%-$36.54M-930%$8.76M-95.5%
-$32.66M-28.2%-$23.68M-20.8%-$22.42M-24.9%-$23.71M-121%-$25.47M-14.9%

FAQ

How much cash does Tyra Biosciences, Inc. generate?
Tyra Biosciences, Inc. (TYRA) generated -$102.3M in operating cash flow over the trailing twelve months.
What is Tyra Biosciences, Inc.'s free cash flow?
After $215.0K of capital expenditures, Tyra Biosciences, Inc.'s free cash flow was -$102.5M over the trailing twelve months, down 39.0% year over year.
Where does Tyra Biosciences, Inc.'s cash flow data come from?
Every line is extracted from Tyra Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.